https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:27851 Thu 17 Mar 2022 14:39:27 AEDT ]]> Alterations in γ-actin and tubulin-targeted drug resistance in childhood leukemia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:992 Sat 24 Mar 2018 08:29:50 AEDT ]]> Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia: an in vivo study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:1006 Sat 24 Mar 2018 08:29:45 AEDT ]]> Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20754 Sat 24 Mar 2018 08:00:25 AEDT ]]>